跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OXY-NASE NASAL DROPS 0.025% - HSA Drug Approval Details
Approvals
/
HSA
/
OXY-NASE NASAL DROPS 0.025%
Approved
THERAPEUTIC
OXY-NASE NASAL DROPS 0.025%
HOE PHARMACEUTICALS SDN BHD
🇸🇬 Health Sciences Authority
Approval Date
Feb 4, 1998
Approval ID
e400a1d6fe9e7408
Company
HOE PHARMACEUTICALS SDN BHD
Type
Therapeutic
Approval Details
Approval Id
e400a1d6fe9e7408
Drug Name
OXY-NASE NASAL DROPS 0.025%
Product Name
OXY-NASE NASAL DROPS 0.025%
Approval Number
SIN09618P
Approval Date
1998-02-04
Registrant
ZUELLIG PHARMA PTE. LTD.
Licence Holder
ZUELLIG PHARMA PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
SOLUTION
Route Of Administration
NASAL
Atc Code
R01AA05
Atc Item Name
oxymetazoline
Pharma Manufacturer Name
ZUELLIG PHARMA PTE. LTD.
Company Detail Path
/organization/zuellig-pharma-pte-ltd
Active Ingredients
OXYMETAZOLINE HCl
0.025% w/v
OXYMETAZOLINE HCL
0.025% W/V
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 4, 1998
Approval ID
e400a1d6fe9e7408
Type
Therapeutic
Back to HSA Approvals